MiRus is pleased to announce the launch of the US multi-center Early Feasibility Study of the Siegel(tm) 8-Fr aortic transcatheter heart valve (THV).
Your privacy is our priority
- Hosted on Secure cloud-based hosting
- SOC II Type 1
- HIPAA compliant
- 2FA authentication
- End-to-end data encryption
- Your health data will not be sold or used without your consent. Ever.
